-
A data and safety monitoring board (DSMB) can be crucial to protecting participants in higher-risk studies, by reviewing the accumulating study data for potential emerging risks and if necessary, by recommending that a study be changed or even halted as a result.
-
As a research institution's human subjects research increases, so must an IRB's work. In some cases this means expanding to handling multicenter protocols, which bring may result in new challenges.
-
Can the informed consent process actually provide too much information?
-
First-in-human clinical trials raise difficult ethical issues for researchers and IRBs because of the uncertainty that accompanies them. Did the preclinical studies that preceded them provide enough information about effectiveness and risks and benefits to proceed with human volunteers?
-
IRB application submissions often lack consistency, have omissions and errors, and other problems that IRBs should teach investigators to anticipate and correct before filing their application. Among these mistakes are policy errors, data security concerns, and other procedural problems.
-
The Vice President's Office for Research at Virginia Commonwealth University in Richmond, VA, has developed a formal process for investigators who wish to appeal an IRB determination.
-
IRB offices routinely handle protocol submissions that are incomplete or flawed in other fundamental ways. These problems cause roadblocks that slow down the IRB approval process and frustrate investigators and IRB staff alike.
-
When internal job mobility is stagnated, it can result in high staff turnover rates a problem no IRB wants to experience.
-
IRB professionals might not have gotten into the business of protecting human subjects because of their love for mathematics and statistics. But many now are finding that tracking data and analyzing numbers helps them do their job better.
-
The state of Michigan has moved forward with its plan to store blood samples left over from screening newborns for medical conditions in a biorepository that will make the deidentified samples available for research.